In conclusion, our results show that mutations of BRAF, KRAS and PIK3CA occur in non-malignant lesions of colorectum demonstrating that these oncogenic alterations are primary genetic events in colorectal carcinogenesis. This evidence concerns the gene BRAF and medical procedure.